N-((het)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

MDE20230265A1Undetermined Publication Date: 2023-03-31KALVISTA PHARMA

View PDF 0 Cites 0 Cited by

Patent Information

Patent Timeline

27 Nov 2014

Priority

26 Nov 2015

Application

MDE20230265T

31 Mar 2023

Publication

MDE20230265A1

IPC: C07D401/14; C07D413/14; A61K31/415; A61K31/454; A61K31/4709; A61K31/497; A61K31/506; C07D231/14; C07D401/06; C07D401/10; C07D403/10; C07D409/14

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.